{"gao_id": "GAO-16-192", "published": "2015-12-15T12:00:00Z", "released": "2016-01-14T07:00:00Z", "summary": "", "title": "Drug Safety: FDA Expedites Many Applications, But Data for Postapproval Oversight Need Improvement", "topics": ["Health Care", "Safety", "Data collection", "Prescription drugs", "Data integrity", "Product evaluation", "Monitoring", "Internal controls", "Reporting requirements", "Program management", "Therapy"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-16-192", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-16-192-highlights.pdf"}, {"title": "Full Report (47 pages)", "url": "https://www.gao.gov/assets/gao-16-192.pdf"}, {"title": "Accessible PDF (57 pages)", "url": "https://www.gao.gov/assets/680/674762.pdf"}]}